Q/C Technologies, Inc. (QCLS) Stock

Q/C Technologies, Inc. (QCLS) is a Healthcare stock trading at $4.02 (as of 2026-06-18), with a market capitalization of $6.55M and a trailing P/E of -0.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Q/C Technologies, Inc. (QCLS) works on quantum-class photonic computing and blockchain-related infrastructure. The company holds exclusive worldwide rights to LightSolver’s light processing unit, which uses laser-based computing for cryptocurrency applications.

Valuation — source: SEC EDGAR (first-party)
Price$4.02
Market Cap$6.55M
P/E Ratio-0.5
Price / Book1.66
Dividend Yield4.0%
DCF Value (model)$-23.32
DCF Upside vs Price-680.1%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$1.58M
Net Margin-246.6%
Return on Equity-56.7%
Current Ratio3.71
Valuation vs Sector & Industry
Stock P/E-0.5
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-102.5%
vs Industry-103.0%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderPrivate Advisor Group, LLC ($1.33M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOJoshua N. Silverman
Employees6
CountryUS
IPO Date2014-01-23

Related Companies (Business model: Clinical Labs / CRO Services; 8 closest by market cap; US-domiciled)

  • Sera Prognostics, Inc. (SERA)
  • Biodesix, Inc. (BDSX)
  • ImmuCell Corporation (ICCC)
  • Advanced Biomed Inc. Common Stock (ADVB)
  • American Shared Hospital Services (AMS)
  • BioNexus Gene Lab Corp. (BGLC)
  • Biomerica, Inc. (BMRA)
  • bioAffinity Technologies, Inc. (BIAF)
QCLS earnings history · QCLS institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.